Additional file 1 of Prognostic value of baseline FDG PET/CT in HER2-positive metastatic breast cancer treated with first-line trastuzumab, pertuzumab, and docetaxel

Figshare 2026 Open access

Read full text
Authors: Marcin Kubeczko, Andrea d’Amico, Olgierd Chrabański, Daria Handkiewicz-Junak, Anna Polakiewicz-Gilowska, K Swiderska, Marta Mianowska-Malec, Aleksandra Leśniak, Barbarba Łanoszka, Natalya Lisovska, Damian Borys, Bartłomiej Pyciński
+4 more Ewa Chmielik, Sławomir Blamek, Aleix Prat, Michal Jarzab
DOI: 10.6084/m9.figshare.31237503
Cited by: 0

Fields of Study & Subjects

HER2/EGFR in Cancer Research Medical Imaging Techniques and Applications Gastric Cancer Management and Outcomes

Publication details

Journal / source
Figshare
Publication date
1 January 2026